These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The evaluation of the efficacy of efferent therapy in patients with acute and chronic kidney failure by the spectrum of blood middle-molecule fractions]. Kon'kova TA; Chudnovskaia MV; Golovanov SA Urol Nefrol (Mosk); 1994; (4):35-7. PubMed ID: 7985299 [TBL] [Abstract][Full Text] [Related]
3. [Blood levels and biological activity of middle weight molecules in critical conditions of the body]. Beliakov NA; Vladyka AS; Malakhova MIa; Solomennikov AV; Shugaev AI Anesteziol Reanimatol; 1987; (3):41-4. PubMed ID: 3631633 [No Abstract] [Full Text] [Related]
4. Methodology for identification of serum middle molecules. Buzio C; Montagna G; Calderini C; Manari A; Migone L Artif Organs; 1981; 4 Suppl():22-7. PubMed ID: 7295090 [TBL] [Abstract][Full Text] [Related]
5. Separation, isolation and amino acid composition of uremic peptides. Shaykh M; Dubin A; Dunea G; Mamdani B; Ahmed S Clin Physiol Biochem; 1984; 2(1):1-13. PubMed ID: 6488692 [TBL] [Abstract][Full Text] [Related]
6. Does lens intrinsic membrane protein MP19 contain a membrane-targeting signal? Chen T; Li X; Yang Y; Erdene AG; Church RL Mol Vis; 2003 Dec; 9():735-46. PubMed ID: 14735063 [TBL] [Abstract][Full Text] [Related]
8. Peptidomic approaches in proteomic research. Jürgens M; Schrader M Curr Opin Mol Ther; 2002 Jun; 4(3):236-41. PubMed ID: 12139309 [TBL] [Abstract][Full Text] [Related]
9. The middle-molecule hypothesis 30 years after: lost and rediscovered in the universe of uremic toxicity? Vanholder R; Van Laecke S; Glorieux G J Nephrol; 2008; 21(2):146-60. PubMed ID: 18446708 [TBL] [Abstract][Full Text] [Related]
10. [Block principle of organization and polyfunctional nature of regulatory peptides]. Kharchenko EP; Ivanova VP; Sokolova TV; Levchenko VF Biokhimiia; 1987 Feb; 52(2):279-89. PubMed ID: 3567250 [TBL] [Abstract][Full Text] [Related]
11. [Vasoactive properties of medium molecular-weight peptides isolated from the blood of dogs with thermal burns]. Val'dman BM; Khshivo AL; Volchegorskiĭ IA; Lifshits RI; Popov GK Patol Fiziol Eksp Ter; 1986; (6):64-7. PubMed ID: 3822540 [No Abstract] [Full Text] [Related]
13. The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components. Seebach D; Beck AK; Bierbaum DJ Chem Biodivers; 2004 Aug; 1(8):1111-239. PubMed ID: 17191902 [TBL] [Abstract][Full Text] [Related]
14. Extracorporeal strategies for the removal of middle molecules. Winchester JF; Audia PF Semin Dial; 2006; 19(2):110-4. PubMed ID: 16551287 [TBL] [Abstract][Full Text] [Related]
17. Proteins involved in the vectorial translocation of nascent peptides across membranes. Meyer DI Prog Clin Biol Res; 1982; 85 Pt B():125-33. PubMed ID: 6750624 [No Abstract] [Full Text] [Related]
18. [Functional state of mitochondria during early burn toxemia and exposure to middle molecular weight blood peptides]. Riabinin VE; Lifshits RI; Charnaia LF; Val'dman BM; Efimenko GP Vopr Med Khim; 1984; 30(3):113-6. PubMed ID: 6474934 [TBL] [Abstract][Full Text] [Related]
19. Review of Growth Inhibitory Peptide as a biotherapeutic agent for tumor growth, adhesion, and metastasis. Muehlemann M; Miller KD; Dauphinee M; Mizejewski GJ Cancer Metastasis Rev; 2005 Sep; 24(3):441-67. PubMed ID: 16258731 [TBL] [Abstract][Full Text] [Related]
20. Micropreparative gel electrophoresis of low-molecular-weight peptides: purification of highly insoluble amyloid peptide fragments. Baumann M; Golabek A; Lalowski M; Wisniewski T Anal Biochem; 1996 May; 236(2):191-8. PubMed ID: 8660494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]